Innotek (688253): The respiratory series products are growing rapidly, and the overseas market outlook is promising.

Event description: The company released its third quarter report for 2024, showing rapid growth in performance: the revenue for the first three quarters of 2024 is approximately 0.521 billion yuan, an increase of 87.05% year-on-year; the net income attributable to the parent company is approximately 0.245 billion yuan, an increase of 18%.

Yongxing SecuritiesDec 3 00:00

innotek (688253.SH): As of the end of November, the company has repurchased a total of 1.1861 million shares.

Glory Exchange reported on December 1 that innotek (688253.SH) announced that as of November 30, 2024, the company repurchased 1,186,052 shares through the trading system of the shanghai securities exchange using a centralized bidding method, accounting for 0.8692% of the company's total share capital of 136,458,196 shares. The highest price for the repurchase was 45.37 yuan/share, the lowest price was 35.93 yuan/share, and the total amount of funds paid was 50,012,613.73 yuan (excluding stamp duty, trading commission, and other transaction costs).

Gelonghui FinanceDec 1 15:54

Innotek (688253): Maintaining high growth, looking forward to winter performance outbreak.

Investment highlights: In the third quarter of 2024, the company's revenue was 0.1 billion yuan (an 81.86% year-on-year increase), net income attributable to the parent company was 0.038 billion yuan (a 320.08% year-on-year increase), and non-GAAP net income was 0.32 billion yuan.

haitong secNov 13 11:52

Express News | Star market in vitro diagnostic company performance is showing a clear warming trend.

BreakingsOct 29 21:41

Innotek (688253): Steady increase in penetration rate, looking forward to increased volume in both domestic and overseas markets in the fourth quarter.

Event: On October 26, 2024, the company released the performance report for the third quarter of 2024. During the reporting period, the company achieved total operating income of 0.521 billion yuan (+87.05%) and net income attributable to the parent company of 0.245 billion yuan (+1.

huaan SecuritiesOct 29 00:00

Third Quarter Report 2024

SZSIOct 26 00:00 · Announcements